Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group. Acta Medica Academica, [S. l.], v. 51, n. 3, p. 217–231, 2023. DOI: 10.5644/ama2006-124.392. Disponível em: https://ama.ba/index.php/ama/article/view/508. Acesso em: 14 aug. 2025.